NCT06774950 (Alliance DT2) is a NA clinical trial of Physician-patient quality circle in Diabetes Mellitus, Type 2, sponsored by Réseau de soins Delta.

Who is sponsoring NCT06774950?

NCT06774950 is sponsored by Réseau de soins Delta.

What drugs are being tested in NCT06774950?

Interventions in NCT06774950: Physician-patient quality circle.

What condition does NCT06774950 study?

NCT06774950 studies Diabetes Mellitus, Type 2.

Is NCT06774950 still recruiting?

NCT06774950 is currently not yet recruiting. Last updated 14 January 2025.

Last reviewed 2025-01-14 · How we verify

NCT06774950: Alliance DT2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Value-based Care in Type 2 Diabetes (Enhancing T2D Care)

Not yet recruiting NA Last updated 14 January 2025

What this trial tests

NA trial testing Physician-patient quality circle in Diabetes Mellitus, Type 2 in 154 participants. Not yet recruiting.

Timeline

1 March 2025

Primary endpoint
1 August 2025

1 March 2027

Quick facts

Lead sponsor	Réseau de soins Delta
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	154
Start date	1 March 2025
Primary completion	1 August 2025
Estimated completion	1 March 2027

Drugs / interventions tested

Physician-patient quality circle

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Réseau de soins Delta

Who can join

Adults 40 to 65, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to obtain a better glycemic index score (decrease) by improving the care and quality of life of type 2 diabetic patients for a possible remission of diabetes. This will be achieved through an intervention that includes a strategy for training primary care physicians and other healthcare professionals in patient therapeutic education (TPE), as well as group and/or individual TPE-related activities/tools made available to patients, funded and encouraged for individualized planning. Intervention follow-up will be carried out by means of quality-of-life questionnaires for patients who have undergone the new method, compared with patients who have received the usual care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial.
Ehlig D, Sapin M, Zeukeng MJ, Vogel J, et al · · 2025 · PMID 41437100 · DOI 10.1186/s13063-025-09302-x
Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial
Ehlig D, Sapin M, Zeukeng M, Vogel J, et al · · 2025 · DOI 10.21203/rs.3.rs-5678340/v1

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Réseau de soins Delta trials

Trials by the same sponsor.

NCT05859555 — Multimodal Educative Data Feedback for Deprescribing BZD and Related Drugs in Outpatients: a Cluster RCT · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06774950 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Réseau de soins Delta
Last refreshed: 14 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06774950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing